跳至主要内容
临床试验/JPRN-UMIN000002531
JPRN-UMIN000002531已完成4 期

Combination Therapy of Angiotensin II Receptor Blocker and Calcium Channel Blocker Exerts Pleiotropic Therapeutic Effects in Addition to Blood Pressure Lowering - Combination Therapy of Angiotensin II Receptor Blocker and Calcium Channel Blocker Exerts Pleiotropic Therapeutic Effects in Addition to Blood Pressure Lowering

Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine0 个研究点目标入组 30 人开始时间: 2009年9月18日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Exclusion criteria included patients who exhibited severe hypertension (clinic systolic >= 180 mmHg and/or diastolic BP >= 110 mmHg), renal insufficiency (estimated glomerular filtration < 30 ml/min/1.73 m2), women who were nursing or pregnant, clinically significant heart disease, moderate-to-severe hepatic dysfunction, and known hypersensitivity to any component of the study medications.

研究者

发起方
Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine

相似试验